Obesity is a serious global health problem, perhaps the biggest public health issue of our
times. Excess body weight may be a factor in carcinogenesis in general, as well as …

Objective To study whether obesity increases the risk of psoriatic arthritis (PsA), given that
obesity is a risk factor for psoriasis and is associated with more severe disease. Design …

Objectives. The objectives of this study were to determine the prevalence of PsA in The
Health Improvement Network (THIN), a large population-based medical records database in …

Abstract Background Psoriatic arthritis (PsA) is a chronic, systemic, inflammatory disorder
characterized by the association of arthritis with psoriasis. Patients with PsA may have a …

Metabolic syndrome (MetS) is a cluster of metabolic and cardiovascular (CV) risk factors
including obesity and visceral adiposity, insulin resistance, dyslipidemia and hypertension …

Background: Moderate to severe plaque psoriasis (with or without psoriatic arthritis) places
significant burden on patients' lives. Objective: Explore and document patients' experiences …

Background. Psoriasis is a chronic inflammatory skin disease affecting 2‐3% of the general
population. Aim. To evaluate the epidemiology and clinical characteristics of patients with …

Objectives Both overall and central obesity have been associated with the risk of psoriasis in
a prospective study. Data on the association between obesity and psoriatic arthritis (PsA) …

Objective. To determine time trends in incidence, prevalence, and clinical characteristics of
psoriatic arthritis (PsA) over a 30-year period. Methods. We identified a population-based …

Background C‐reactive protein (CRP), an inflammation biomarker, indicates cardiovascular
risk and is elevated in psoriasis. The effect of etanercept on CRP in psoriasis has not been …